Found 0 matching trials
Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)
EARLY_PHASE1This is a pilot study to measure levels of albumin and inflammatory cytokin...
Location
Wilmer Eye Institute, Johns Hopkins Hospital
Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis
EARLY_PHASE1The goal of the study is to determine the earliest structural changes in th...
Location
Neuro Ophthalmology
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
PHASE4This pilot study is designed as a prospective cohort study to determine whe...
Location
The MS Center at the Neurology Center in Southern California
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
PHASE2This 8-week randomized, open-label evaluation will examine the acute safety...
Location
Questcor Investigational Site
Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel
PHASE4This study will examine the clinical response, cytokine expression and join...
Location
Iraj Sabahi Research Inc
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
PHASE4The purpose of this study is to provide nephrologists with additional clini...
Location
Mallinckrodt Investigational Site